Eris Lifesciences Ltd (BOM:540596)
₹ 1466.75 -9.55 (-0.65%) Market Cap: 199.63 Bil Enterprise Value: 224.52 Bil PE Ratio: 57.35 PB Ratio: 7.20 GF Score: 94/100

Q4 2022 Eris Lifesciences Ltd Earnings Call Transcript

May 04, 2022 / 10:30AM GMT
Release Date Price: ₹663.2 (-1.56%)
Operator

Ladies and gentlemen, good day, and welcome to Q4 and FY '22 Conference Call of Eris Life Sciences. We have with us on the call today Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V. Krishnakumar, Chief Operating Officer and Executive Director. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. V. Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you sir.

Krishnakumar Vaidyanathan
Eris Lifesciences Limited - Executive Director & COO

Thank you. Good afternoon, and welcome to our fourth quarter conference call. I'm Krishnakumar, and I'm happy to connect with you today. At the outset, I'm delighted to inform you that Eris has entered the elite club of Indian pharma companies to have crossed INR 400 crores of profit after tax in just 15 years from inception. There are less than a handful of pharma companies in these categories. We have delivered an EPS growth of 14% in this financial year on the back of a 21% EPS growth, which we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot